相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Design, synthesis and antimycobacterial evaluation of novel 3-substituted-N-aryl-6,7-dimethoxy-3a,4-dihydro-3H-indeno[1,2-c]pyrazole-2-carboxamide analogues
Mohamed Jawed Ahsan et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2011)
Synthesis and biological evaluation of sugar-derived chiral nitroimidazoles as potential antimycobacterial agents
G. Mugunthan et al.
CARBOHYDRATE RESEARCH (2011)
Design and synthesis of novel cell wall inhibitors of Mycobacterium tuberculosis GlmM and GlmU
Yongmeng Li et al.
CARBOHYDRATE RESEARCH (2011)
Tuberculosis drugs: new candidates and how to find more
Claudia Sala et al.
FUTURE MICROBIOLOGY (2011)
Nanocarriers for pulmonary administration of peptides and therapeutic proteins
Fernanda Andrade et al.
NANOMEDICINE (2011)
Advent of Imidazo[1,2-a]pyridine-3-carboxamides with Potent Multi- and Extended Drug Resistant Antituberculosis Activity
Garrett C. Moraski et al.
ACS MEDICINAL CHEMISTRY LETTERS (2011)
New old challenges in tuberculosis: Potentially effective nanotechnologies in drug delivery
Alejandro Sosnik et al.
ADVANCED DRUG DELIVERY REVIEWS (2010)
Development of Nanoparticles for Antimicrobial Drug Delivery
L. Zhang et al.
CURRENT MEDICINAL CHEMISTRY (2010)
The chemical biology of new drugs in the development for tuberculosis
Clifton E. Barry et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2010)
Current Pharmaceutical Design of Antituberculosis Drugs: Future Perspectives
Alejandro Speck-Planche et al.
CURRENT PHARMACEUTICAL DESIGN (2010)
Micro- and nanocarrier-mediated lung targeting
Balak D. Kurmi et al.
EXPERT OPINION ON DRUG DELIVERY (2010)
New drugs and regimens for treatment of TB
Eric Leibert et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2010)
Recent advances in the design and synthesis of heterocycles as anti-tubercular agents
Prem M. S. Chauhan et al.
FUTURE MEDICINAL CHEMISTRY (2010)
R207910 (TMC207): A new antibiotic for the treatment of tuberculosis
N. Lounis et al.
MEDECINE ET MALADIES INFECTIEUSES (2010)
Production of TNF-α, IL-12(p40) and IL-17 Can Discriminate between Active TB Disease and Latent Infection in a West African Cohort
Jayne S. Sutherland et al.
PLOS ONE (2010)
Current development and future prospects in chemotherapy of tuberculosis
Eric L. Nuermberger et al.
RESPIROLOGY (2010)
Development of New Anti-tuberculosis Drug Candidates
Ruiru Shi et al.
TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE (2010)
The mechanisms and consequences of the extra-pulmonary dissemination of Mycobacterium tuberculosis
Nitya Krishnan et al.
TUBERCULOSIS (2010)
Tuberculosis drug development: Progress, challenges, and the road ahead
Ann M. Ginsberg
TUBERCULOSIS (2010)
New Antituberculous Drugs in Development
Umesh G. Lalloo et al.
Current HIV/AIDS Reports (2010)
Synthesis and evaluation of rifabutin analogs against Mycobacterium avium and H37Rv, MDR and NRP Mycobacterium tuberculosis
Ricardo Figueiredo et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2009)
Who Benefits from Granulomas, Mycobacteria or Host?
Tyler D. Bold et al.
CELL (2009)
Ultrasound, liposomes, and drug delivery: principles for using ultrasound to control the release of drugs from liposomes
Avi Schroeder et al.
CHEMISTRY AND PHYSICS OF LIPIDS (2009)
Do Nanomedicines Require Novel Safety Assessments to Ensure their Safety for Long-Term Human Use?
Peter Hoet et al.
DRUG SAFETY (2009)
Delivery of antibiotics to the respiratory tract: an update
Daniela Traini et al.
EXPERT OPINION ON DRUG DELIVERY (2009)
Lipid nanocapsules: A new platform for nanomedicine
N. T. Huynh et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2009)
Evaluation of antitubercular drug-loaded surfactants as inhalable drug-delivery systems for pulmonary tuberculosis
G. Chimote et al.
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A (2009)
Novel Generation Mycobacterial Adjuvant Based on Liposome-Encapsulated Monomycoloyl Glycerol from Mycobacterium bovis Bacillus Calmette-Guerin
Claire A. Swetman Andersen et al.
JOURNAL OF IMMUNOLOGY (2009)
Liposome-based cationic adjuvant formulations (CAF): Past, present, and future
Dennis Christensen et al.
JOURNAL OF LIPOSOME RESEARCH (2009)
Treatment of Active Pulmonary Tuberculosis in Adults: Current Standards and Recent Advances Insights from the Society of Infectious Diseases Pharmacists
Ronald G. Hall et al.
PHARMACOTHERAPY (2009)
Liposomes and nanoparticles: nanosized vehicles for drug delivery in cancer
Yogeshkumar Malam et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2009)
The Past and Future of Tuberculosis Research
Inaki Comas et al.
PLOS PATHOGENS (2009)
Targeted delivery of nanoparticles for the treatment of lung diseases
Shirzad Azarmi et al.
ADVANCED DRUG DELIVERY REVIEWS (2008)
Mycobacterium tuberculosis and the macrophage: Maintaining a balance
Jean Pieters
CELL HOST & MICROBE (2008)
Mannose-targeted systems for the delivery of therapeutics
Juan M. Irache et al.
EXPERT OPINION ON DRUG DELIVERY (2008)
Rifabutin encapsulated in liposomes exhibits increased therapeutic activity in a model of disseminated tuberculosis
M. M. Gaspar et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2008)
Efficient targeting to alveolar macrophages by intratracheal administration of mannosylated liposomes in rats
Wassana Wijagkanalan et al.
JOURNAL OF CONTROLLED RELEASE (2008)
A novel application of affinity biosensor technology to detect antibodies to mycolic acid in tuberculosis patients
Simon T. Thanyani et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2008)
Emerging nanopharmaceuticals
Willie E. Bawarski et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2008)
Nanomedicine: Application of nanobiotechnology in medical practice
K. K. Jain
MEDICAL PRINCIPLES AND PRACTICE (2008)
Multifunctional nanoparticles - properties and prospects for their use in human medicine
Nuria Sanvicens et al.
TRENDS IN BIOTECHNOLOGY (2008)
Foamy Macrophages from Tuberculous Patients' Granulomas Constitute a Nutrient-Rich Reservoir for M-tuberculosis Persistence
Pascale Peyron et al.
PLOS PATHOGENS (2008)
Nanoparticles: pharmacological and toxicological significance
C. Medina et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
Liposomes for drug delivery to the lungs by nebulization
Marco Zaru et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2007)
Interactions of pathogenic mycobacteria with host macrophages
Varadharajan Sundaramurthy et al.
MICROBES AND INFECTION (2007)
Targeted drug delivery to enhance efficacy and shorten treatment duration in disseminated Mycobacterium avium infection in mice
Jurriaan E. M. de Steenwinkel et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2007)
Mycobacterial glycolipid trehalose 6,6′-dimycolate-induced hypersensitive granulomas:: contribution of CD4+ lymphocytes
Tera V. Guidry et al.
MICROBIOLOGY-SGM (2007)
Nanoparticles:: Characteristics, mechanisms of action, and toxicity in pulmonary drug delivery -: A review
Simardeep Gill et al.
JOURNAL OF BIOMEDICAL NANOTECHNOLOGY (2007)
Biological evaluation of pyrazinamide liposomes for treatment of Mycobacterium tuberculosis
M. S. El-Ridy et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2007)
Nanomedicine: Developing smarter therapeutic and diagnostic modalities
Omid C. Farokhzad et al.
ADVANCED DRUG DELIVERY REVIEWS (2006)
New-concept chemotherapy by nanoparticles of biodegradable polymers: where are we now?
Si-Shen Feng
NANOMEDICINE (2006)
RUTI: A new chance to shorten the treatment of latent tuberculosis infection
Pere-Joan Cardona
TUBERCULOSIS (2006)
Nanomedicine for respiratory diseases
U Pison et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2006)
Origin and development of RUTI, a new therapeutic vaccine against Mycobacterium tuberculosis infection
P. J. Cardona et al.
ARCHIVOS DE BRONCONEUMOLOGIA (2006)
Antitubercular inhaled therapy: opportunities, progress and challenges
R Pandey et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2005)
Nanomedicine: current status and future prospects
SM Moghimi et al.
FASEB JOURNAL (2005)
The Mycobacterium tuberculosis cell wall component mycolic acid elicits pathogen-associated host innate immune responses
J Korf et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2005)
Lipid vesicles in capillary electrophoretic techniques: Characterization of structural properties and associated membrane-molecule interactions
RL Owen et al.
ELECTROPHORESIS (2005)
Preparation and characterization of liposomes encapsulating chitosan nanoparticles
YZ Huang et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2005)
Role of nanotechnology in targeted drug delivery and imaging: a concise review
Otilia M. Koo et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2005)
Design of liposomal aerosols for improved delivery of rifampicin to alveolar macrophages
SP Vyas et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2004)
Nebulization of liposome encapsulated antitubercular drugs in guinea pigs
R Pandey et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2004)
Mycobacterial granulomas: keys to a long-lasting host-pathogen relationship
DO Co et al.
CLINICAL IMMUNOLOGY (2004)
Liposome/water lipophilicity: Methods, information content, and pharmaceutical applications
GP van Balen et al.
MEDICINAL RESEARCH REVIEWS (2004)
Immunization with a mycobacterial lipid vaccine improves pulmonary pathology in the guinea pig model of tuberculosis
CC Dascher et al.
INTERNATIONAL IMMUNOLOGY (2003)
Incorporation of antibiotics in liposomes designed for tuberculosis therapy by inhalation
OR Justo et al.
DRUG DELIVERY (2003)
Interaction of rifampicin and isoniazid with large unilamellar liposomes: spectroscopic location studies
C Rodrigues et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2003)
Liposomes: Has the magic bullet hit the target?
NC Santos et al.
QUIMICA NOVA (2002)
Chemotherapeutic activity against murine tuberculosis of once weekly administered drugs (isoniazid and rifampicin) encapsulated in liposomes
S Labana et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2002)
The activity of low-clearance liposomal amikacin in experimental murine tuberculosis
J Dhillon et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2001)
Developments in liposomal drug delivery systems
N Maurer et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2001)
Restraining mycobacteria: Role of granulomas in mycobacterial infections
BM Saunders et al.
IMMUNOLOGY AND CELL BIOLOGY (2000)
Tuftsin-bearing liposomes in treatment of macrophage-based infections
AK Agrawal et al.
ADVANCED DRUG DELIVERY REVIEWS (2000)
分享论文
